Fig. 7

(Analysis 1.4): Chinese patent medicine Tongfengding capsules plus conventional treatment versus conventional treatment. Outcome 4: Inflammatory factor (IL-6, IL-8, and TNF-α). IL: interleukin, TNF-α: tumor necrosis factor-alpha
(Analysis 1.4): Chinese patent medicine Tongfengding capsules plus conventional treatment versus conventional treatment. Outcome 4: Inflammatory factor (IL-6, IL-8, and TNF-α). IL: interleukin, TNF-α: tumor necrosis factor-alpha